Equillium Stock Filter Stocks by Fundamentals

EQ Stock  USD 2.31  0.25  12.14%   
Equillium fundamentals help investors to digest information that contributes to Equillium's financial success or failures. It also enables traders to predict the movement of Equillium Stock. The fundamental analysis module provides a way to measure Equillium's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Equillium stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Equillium Debt to Equity Analysis

Equillium Debt to Equity Driver Correlations

Understanding the fundamental principles of building solid financial models for Equillium is extremely important. It helps to project a fair market value of Equillium Stock properly, considering its historical fundamentals such as Debt to Equity. Since Equillium's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Equillium's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Equillium's interrelated accounts and indicators.
0.310.920.570.96-0.87-0.730.55-0.380.650.90.840.90.550.76-0.911.00.9-0.850.810.520.350.690.80.29
0.310.30.410.46-0.09-0.37-0.370.140.50.360.450.34-0.130.06-0.470.310.21-0.680.310.29-0.610.290.410.64
0.920.30.270.96-0.71-0.440.27-0.340.560.750.670.720.240.8-0.950.920.99-0.810.590.190.120.430.640.02
0.570.410.270.44-0.75-0.930.61-0.310.560.760.750.810.770.02-0.330.560.22-0.540.820.890.440.860.690.69
0.960.460.960.44-0.75-0.60.31-0.370.690.820.770.80.310.79-0.970.960.92-0.920.690.390.090.550.710.29
-0.87-0.09-0.71-0.75-0.750.79-0.730.59-0.55-0.87-0.75-0.89-0.72-0.460.64-0.86-0.70.62-0.82-0.63-0.63-0.76-0.67-0.26
-0.73-0.37-0.44-0.93-0.60.79-0.720.37-0.66-0.89-0.91-0.93-0.85-0.330.49-0.73-0.390.69-0.95-0.94-0.49-0.96-0.85-0.67
0.55-0.370.270.610.31-0.73-0.72-0.480.320.630.590.690.930.36-0.20.540.29-0.230.720.720.930.730.560.2
-0.380.14-0.34-0.31-0.370.590.37-0.48-0.54-0.42-0.36-0.44-0.3-0.420.25-0.38-0.270.33-0.44-0.45-0.41-0.4-0.14-0.17
0.650.50.560.560.69-0.55-0.660.32-0.540.690.750.70.340.53-0.70.650.47-0.860.660.630.070.570.660.57
0.90.360.750.760.82-0.87-0.890.63-0.420.690.970.990.740.55-0.730.890.72-0.810.970.710.420.910.930.36
0.840.450.670.750.77-0.75-0.910.59-0.360.750.970.970.720.56-0.70.840.63-0.840.970.770.320.930.960.49
0.90.340.720.810.8-0.89-0.930.69-0.440.70.990.970.780.54-0.710.890.68-0.80.980.770.470.930.920.43
0.55-0.130.240.770.31-0.72-0.850.93-0.30.340.740.720.780.21-0.20.550.26-0.30.830.80.830.870.730.31
0.760.060.80.020.79-0.46-0.330.36-0.420.530.550.560.540.21-0.790.770.79-0.690.480.230.150.340.510.08
-0.91-0.47-0.95-0.33-0.970.640.49-0.20.25-0.7-0.73-0.7-0.71-0.2-0.79-0.91-0.920.91-0.58-0.270.0-0.42-0.68-0.23
1.00.310.920.560.96-0.86-0.730.54-0.380.650.890.840.890.550.77-0.910.9-0.850.80.520.350.680.80.29
0.90.210.990.220.92-0.7-0.390.29-0.270.470.720.630.680.260.79-0.920.9-0.730.560.120.170.40.63-0.09
-0.85-0.68-0.81-0.54-0.920.620.69-0.230.33-0.86-0.81-0.84-0.8-0.3-0.690.91-0.85-0.73-0.73-0.550.06-0.61-0.78-0.54
0.810.310.590.820.69-0.82-0.950.72-0.440.660.970.970.980.830.48-0.580.80.56-0.730.830.490.980.920.46
0.520.290.190.890.39-0.63-0.940.72-0.450.630.710.770.770.80.23-0.270.520.12-0.550.830.480.880.670.79
0.35-0.610.120.440.09-0.63-0.490.93-0.410.070.420.320.470.830.150.00.350.170.060.490.480.510.32-0.07
0.690.290.430.860.55-0.76-0.960.73-0.40.570.910.930.930.870.34-0.420.680.4-0.610.980.880.510.870.51
0.80.410.640.690.71-0.67-0.850.56-0.140.660.930.960.920.730.51-0.680.80.63-0.780.920.670.320.870.38
0.290.640.020.690.29-0.26-0.670.2-0.170.570.360.490.430.310.08-0.230.29-0.09-0.540.460.79-0.070.510.38
Click cells to compare fundamentals
Competition

Equillium Total Stockholder Equity

Total Stockholder Equity

21.44 Million

At this time, Equillium's Total Stockholder Equity is relatively stable compared to the past year.
According to the company disclosure, Equillium has a Debt to Equity of 0.0null. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Debt to Equity (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Portfolio Comparator Now

   

Portfolio Comparator

Compare the composition, asset allocations and performance of any two portfolios in your account
All  Next Launch Module

Equillium Fundamentals

About Equillium Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Equillium's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Equillium using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Equillium based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California. Equillium operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 45 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Equillium in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Equillium's short interest history, or implied volatility extrapolated from Equillium options trading.

Pair Trading with Equillium

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Equillium position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will appreciate offsetting losses from the drop in the long position's value.

Moving against Equillium Stock

  0.8VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.78MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.76KA Kineta Inc Financial Report 9th of May 2024 PairCorr
  0.76ME 23Andme HoldingPairCorr
  0.75MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to Equillium could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Equillium when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Equillium - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Equillium to buy it.
The correlation of Equillium is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Equillium moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Equillium moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Equillium can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Equillium is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Equillium Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Equillium Stock. Highlighted below are key reports to facilitate an investment decision about Equillium Stock:
Check out Equillium Piotroski F Score and Equillium Altman Z Score analysis.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Equillium Stock analysis

When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stocks Directory
Find actively traded stocks across global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Is Equillium's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Equillium. If investors know Equillium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Equillium listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.38)
Revenue Per Share
1.039
Quarterly Revenue Growth
(0.42)
Return On Assets
(0.14)
Return On Equity
(0.49)
The market value of Equillium is measured differently than its book value, which is the value of Equillium that is recorded on the company's balance sheet. Investors also form their own opinion of Equillium's value that differs from its market value or its book value, called intrinsic value, which is Equillium's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equillium's market value can be influenced by many factors that don't directly affect Equillium's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Equillium's value and its price as these two are different measures arrived at by different means. Investors typically determine if Equillium is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.